Table 4.
Adverse effects.
Adverse effects | Articles |
---|---|
AE related to mesenchymal cell therapy | 14,16,17,23,31,33,38 |
AE not related to mesenchymal cell therapy | 13,16,17,19,21,25–27,29,30,32,38,63 |
AE during the infusion | 16,17,31,33 |
No AE | 11,12,15,18,20,22,24,28,34–37 |
AE related to mesenchymal cell therapy | Articles |
Worsening of Bradycardia | 14 |
Hypoxemia Hypotension and/or hypertension Muscle spasms |
16 |
Transient facial flushing Fever |
17 |
Liver dysfunction Heart failure Allergic rash |
23 |
Diarrhea Rash in the chest area |
31 |
Single CTCAE grade 1 | 33 |
Transient shivering | 38 |
AE not related to mesenchymal cell therapy | Articles |
Repeated pulmonary infections Empyema |
13 |
Lower-extremity arterial thrombosis Epistaxis and hematuria |
16 |
Hypoxemia | 17 |
Pneumothorax | 19 |
Bacterial pneumonia Septic shock |
21 |
Nosocomial pneumonia | 25 |
Respiratory arrest Sepsis Embolic infarcts |
26 |
Cardiopulmonary arrest | 27,38 |
Hypoxic respiratory failure Pulmonary embolism Acute renal failure Expiration |
29 |
Disseminated fungal infection and intra-abdominal sepsis | 30 |
Massive gastrointestinal bleeding Hypotension Tachycardia Pneumonia Fungal infection by Candida spp. |
32 |
Lung transplant rejection | 63 |